Celeris Therapeutics

Enabling happier and healthier lives by predicting biomolecular interactions and designing drugs for incurable diseases.

[Celeris Therapeutics @CelerisTx]

📣 Thrilled to announce that Federica Ponti, our distinguished biologist, will be delivering a keynote presentation at the upcoming ACE Drug Discovery Summit next month. If you're attending, seize the opportunity to hear Federica and connect with the CelerisTx team! 🌐

[Celeris Therapeutics @CelerisTx]

📣 Speaker Alert! We are thrilled to announce that our VP and Head of Drug Discovery, Chris Tame, will be speaking at the upcoming TPD Europe conference next month. His presentation is truly ‘not to be missed’.
#TPDEurope#TPD#TCP#PROTAC#Science

[Celeris Therapeutics @CelerisTx]

🌟 Exciting News! 🌟
We are thrilled to announce the appointment of Dr. John Harling as Chair of the CelerisTx Scientific Advisory Board! 🎉🚀
#ScientificAdvisoryBoard #ProteinDegradation #Innovation #CelerisTx

[Celeris Therapeutics @CelerisTx]

🚀 CelerisTx starts 2024 by proudly welcoming Dr. Agnieszka Konopacka to our team as Head of Biology! Aga brings over 10 years of industry experience from Pfizer and GSK, where she was leading multiple TPD technology development and drug discovery projects.
🎉#TeamWelcome

[Celeris Therapeutics @CelerisTx]

“We're thrilled with the outcomes stemming from our partnership with Boehringer. This collaboration underscores our proficiency in designing selective degraders on challenging targets using our innovative platform.” from Christopher Trummer, CEO and co-founder at CelerisTx. (6/6)

[Celeris Therapeutics @CelerisTx]

Thrilled to share exciting progress from our collaboration with @Boehringer! 🤝
In April 2022, CelerisTx and @Boehringer entered in a collaboration to develop selective de-novo degrader molecules for pathogenic proteins, harnessing CelerisTx’s proprietary AI-based platform. (1/6)

[Celeris Therapeutics @CelerisTx]

"The commitment to succeed and deliver is remarkable and commendable, so well done to everyone involved.“ from Dr Heinz Stadtmueller, Senior Director, Medicinal Chemistry at Boehringer Ingelheim. (5/6)

[Celeris Therapeutics @CelerisTx]

🚀 2023 has been a whirlwind year for CelerisTx! 🌟 We've onboarded fresh talents and expanded our footprint to London 🇬🇧 spearheading our drug discovery initiatives. 🚀 Ready and geared up for a phenomenal 2024!
🌟 #CelerisTx #BiotechInnovations #ScienceAtItsBest 🚀

[Celeris Therapeutics @CelerisTx]

🌟 Our London Team is Growing Again! 🚀 This month, we're delighted to extend a warm welcome to Louisa Anderson and Robert Griffiths! 👩‍🔬 🎉 We're thrilled to have you both join us and eagerly anticipate achieving great things together! #WelcomeToTheTeam #NewHire #Innovation

[Celeris Therapeutics @CelerisTx]

🎤 Alzbeta Tuerkova from the CelerisTx CADD group has been invited to speak at the upcoming PROXIDRUGS Lecture Series!
check out the details here: https://t.co/qUWS6KElj9

[Celeris Therapeutics @CelerisTx]

🎉 Exciting News! 🎤 Chris Tame, our Vice President and Head of Drug Discovery, is scheduled to speak at the AI-driven Drug Discovery Summit in Boston in early December! Seize this opportunity to connect with Chris! 🚀
#AI #ProteinDegradation #Innovation #DrugDiscovery #CelerisTx

[Katherine A Donovan @kdonovan1008]

Looking forward to our AI focused session this Thursday at 11am EDT!

[Celeris Therapeutics @CelerisTx]

We look forward to #TechBio UK tomorrow in London! 🌐 If you're interested in learning more about our #AI -driven platform, how #CelerisTx leverages data to drive its pipeline, and our team of #TargetedProteinDegradation (TPD) experts, reach out to Honorine at TechBioUK! 🤝

[Celeris Therapeutics @CelerisTx]

Big thanks to #BiotechAustria and Human Technology Styria for organizing a fantastic summit in Graz! 🌟 Honorine Lebraud and Jakob Hohenberger had a great time at the Biotech Summit Austria last week. 🌐 #BiotechSummitAustria #Networking #Graz

[Celeris Therapeutics @CelerisTx]

🚀 Conference Alert! 🌐 Honorine Lebraud will be representing CelerisTx at the Biotech Summit Austria in Graz this week! 📅 It's not too late to register and meet with Honorine there! 🤝 Don't miss out on this exciting opportunity!

#BiotechSummit #Austria #Innovation

[Celeris Therapeutics @CelerisTx]

Our London team is growing! 🚀 Welcome to Morag Watson, who is joining our medicinal chemistry team! 👩‍🔬 We are looking forward to working with you, Morag! 🎉
#WelcomeToTheTeam #NewHire #Innovation #Teamwork
Read moreabout CelerisTx here: https://t.co/r5Df91UUmB

[Celeris Therapeutics @CelerisTx]

🌐 This week, our Head of Platform, Andrew Potterton, will be attending BioTechX in Basel. 🔍 Don't hesitate to reach out to Andrew and learn more about CelerisTx AI-driven platform! 🚀

#BioTechX #AI #ML #DrugDiscovery #ProteinDegraders #Innovation